Nearly 30 million U.S. adults, about 1 in 8, reported a voice problem in 2022, up from roughly 1 in 13 a decade earlier (Naunheim et al., The Laryngoscope 2024). That rise tracks a broader pattern: adults had 1.6 times higher odds of reporting dysphonia in 2022 than in 2012 (American Journal of Speech-Language Pathology, 2024). Among the hardest-hit group, schoolteachers, the pooled point prevalence of voice disorders is 37.7 percent and the lifetime rate reaches 63.1 percent (Journal of Voice worldwide meta-analysis, 2025). Yet only 5 to 20 percent of affected people ever see a doctor (Duke Health). This analysis consolidates data from the NIDCD, ASHA, The Laryngoscope, the Journal of Voice, and more than 20 other primary sources to map how common voice disorders are, who they hit hardest, and what they cost.
This roundup covers the conditions themselves: prevalence, causes, and costs. For the clinicians who treat them and the therapy market, see our companion speech therapy statistics, which cites separate profession and market figures. Nothing here is medical advice.
TL;DR
- 29.9 million U.S. adults (12.2 percent) reported a voice problem in the past year in 2022 (Naunheim et al., The Laryngoscope 2024).
- Reported dysphonia rose from 17.89 million adults (7.62 percent) in 2012 to 29.92 million (11.71 percent) in 2022 (American Journal of Speech-Language Pathology, 2024).
- Close to 1 in 5 Americans has had a voice disorder in their lifetime (Huston et al., The Laryngoscope 2024).
- Teachers show a pooled point prevalence of 37.7 percent and a 63.1 percent lifetime rate (Journal of Voice, 2025).
- Call center employees during the pandemic reported voice problems at 57.6 percent (call-center study, 2024).
- In a 55-million-person database, dysphonia point prevalence was just 0.98 percent, showing most cases go untreated (Cohen et al., The Laryngoscope 2012).
- Voice disorders in older adults reach a pooled prevalence of 18.79 percent (American Journal of Speech-Language Pathology meta-analysis, 2023).
- Direct U.S. healthcare costs were estimated at 11 to 13 billion dollars, comparable to COPD and asthma (Cohen et al., via Duke Health).
- Women carry a higher lifetime prevalence than men, 46.3 percent versus 36.9 percent (gender-differences study, PMC 2022).
- The American Cancer Society estimates about 12,290 new laryngeal cancer cases in the U.S. in 2026 (American Cancer Society, 2026).
1. U.S. Prevalence and the Post-Pandemic Rise
The headline finding of the last two years is direction, not just level. Multiple independent surveys using the National Health Interview Survey converge on a climbing rate of self-reported voice problems, with the sharpest signal among women and people with long-COVID symptoms. Reported dysphonia jumped from 7.62 percent of adults in 2012 to 11.71 percent in 2022, a 1.6-fold increase in odds (American Journal of Speech-Language Pathology, 2024). The NIDCD’s baseline figure of 17.9 million adults (7.6 percent) reflects the older 2012 survey and now reads as a floor, not a ceiling.
| Metric | Value | Source |
|---|---|---|
| U.S. adults reporting a voice problem in past year (2022) | 29.9 million (12.2%) | Naunheim et al., The Laryngoscope 2024 |
| Adults reporting dysphonia, 2012 vs 2022 | 17.89M (7.62%) to 29.92M (11.71%) | Am. J. Speech-Language Pathology, 2024 |
| Higher odds of reporting dysphonia, 2022 vs 2012 | OR 1.60 | Am. J. Speech-Language Pathology, 2024 |
| Adults affected by dysphonia, 2022 | 1 in 8.5 | Am. J. Speech-Language Pathology, 2024 |
| Lifetime prevalence, national survey | ~1 in 5 (20%) | Huston et al., The Laryngoscope 2024 |
| Current voice disorder, national survey | 12.6% | Huston et al., The Laryngoscope 2024 |
| Long-COVID adults with voice complaints vs without | 21.1% vs 11.6% | Naunheim et al., The Laryngoscope 2024 |
Context: the NIDCD reports these self-report figures come from the National Health Interview Survey and were last updated July 2025 (NIDCD Quick Statistics); the trend data comes from Naunheim et al. and the 2012-to-2022 comparison.
2. Occupational Voice Users: Teachers, Call Centers, and Performers
Voice is the primary tool of 5 to 10 percent of the workforce, and the prevalence data for those groups dwarfs the general population. Teachers are the most-studied cohort, but call center operators and singers show comparable or higher rates once cumulative career exposure is counted. A 2025 meta-analysis of 62 studies and 100,684 participants pinned teacher lifetime prevalence at 63.1 percent, more than double the general adult rate. The same divergence appears in classic case-control work: teachers report current voice problems at 8.7 percent versus 2.9 percent for non-teachers.
| Metric | Value | Source |
|---|---|---|
| Teachers, pooled point prevalence | 37.7% | Journal of Voice worldwide meta-analysis, 2025 |
| Teachers, lifetime prevalence | 63.1% | Journal of Voice worldwide meta-analysis, 2025 |
| Teachers vs non-teachers, current voice problem | 8.7% vs 2.9% | Roy et al., J. Speech Lang. Hear. Res. 2004 |
| Call center operators, career prevalence | 33% to 68% | Journal of Voice systematic review, 2021 |
| Call center employees, voice problems (pandemic) | 57.6% | Call-center study, 2024 |
| Professional voice users (singers, teachers, actors) | ~50% | ASHA Practice Portal |
| Workforce relying on voice as primary tool | 5% to 10% | Verdolini and Ramig, via Duke Health |
Performers sit at the extreme end: reported voice-disorder prevalence among singers ranges from 16.3 to 64.0 percent depending on style and measurement (ASHA). Vocal strain among streamers, voice actors, and broadcasters is the same occupational story in a newer medium, a bridge we explore in our voice acting industry statistics. Primary sources: Journal of Voice teacher meta-analysis, Roy et al. 2004, and the call-center systematic review.
3. The Conditions: Nodules, Laryngitis, and Dysphonia Types
Prevalence collapses dramatically the moment you require a clinical diagnosis rather than a self-report, which is the single clearest signal that most voice disorders go undiagnosed. In a database of nearly 55 million people, only 0.98 percent carried a dysphonia diagnosis, against the 3 to 9 percent the general population is estimated to experience. The most common specific diagnoses were acute laryngitis, nonspecific dysphonia, benign vocal fold lesions, and chronic laryngitis.
| Metric | Value | Source |
|---|---|---|
| Dysphonia point prevalence, treatment-seeking (55M people) | 0.98% | Cohen et al., The Laryngoscope 2012 |
| Dysphonia, female vs male (treatment-seeking) | 1.2% vs 0.7% | Cohen et al., The Laryngoscope 2012 |
| Vocal nodules, general population | 1.31% | Epidemiological study, PMC 2017 |
| Vocal polyps, general population | 0.31% to 0.55% | Merck Manual / epidemiological studies |
| Benign vocal fold lesions, national epidemiologic range | 2.5% to 7.7% | U.S. and South Korea national studies |
| Spasmodic dysphonia, estimated U.S. cases | 10,000 to 30,000 | National Spasmodic Dysphonia Association |
| Laryngeal cancer, estimated new U.S. cases (2026) | 12,290 | American Cancer Society, 2026 |
Outlier note: laryngeal cancer incidence is falling roughly 2 to 3 percent a year, attributed largely to declining smoking rates, and about 60 percent of cases start in the glottis where the vocal cords sit (American Cancer Society). Primary sources: Cohen et al. 2012, the vocal nodules epidemiological study, and American Cancer Society key statistics.
4. Demographics: Age, Sex, and Children
Risk is not evenly distributed. It concentrates in older adults, in women, and, for specific lesions, in young children. Voice disorders in older adults reach a pooled prevalence of 18.79 percent, roughly double the working-age rate, and climb to 33.03 percent among institutionalized seniors. The sex gap is consistent across data sources and is linked to hormonal fluctuation and thinner vocal-fold tissue.
| Metric | Value | Source |
|---|---|---|
| Older adults, pooled prevalence | 18.79% | Am. J. Speech-Language Pathology meta-analysis, 2023 |
| Institutionalized vs community-dwelling older adults | 33.03% vs 15.2% | Am. J. Speech-Language Pathology, 2023 |
| Voice-disorder lifetime prevalence, college young adults | 33.9% | J. Speech Lang. Hear. Res., 2016 |
| U.S. children (3-17) with voice disorder lasting 1+ week | 1.4% | NIDCD (NHIS) |
| Women vs men, lifetime prevalence | 46.3% vs 36.9% | Gender-differences study, PMC 2022 |
| Postmenopausal vocal-symptom prevalence range | 17% to 77% | Reproductive/hormonal review, PMC |
Context: female vocal folds are about 20 to 30 percent thinner than male folds, offering less tissue to absorb vibratory force (gender-differences literature). Related sensory-health conditions such as tinnitus follow their own demographic curves, covered in our tinnitus statistics. Primary sources: older-adults meta-analysis and the gender-differences study.
5. The Economic Burden and Lost Productivity
Voice disorders behave economically like a chronic disease, and most of the cost hides in presenteeism rather than doctor bills. Per short-term disability claim, voice disorders averaged 39.2 lost workdays, on par with heart disease, and produced 3,408 dollars in disability payments plus 4,437 dollars in lost wages. A Miami-Dade teacher study found roughly 12 million dollars a year in presenteeism costs against just 1 million in absenteeism, showing how much productivity leaks before anyone misses a shift.
| Metric | Value | Source |
|---|---|---|
| U.S. annual direct healthcare cost of voice disorders | $11 to 13 billion | Cohen et al., via Duke Health (2009 est.) |
| Mean workdays absent per short-term disability claim | 39.2 | Duke Health study |
| Mean short-term disability payment per voice claim (12 mo) | $3,408.68 | Duke Health study |
| Mean lost wages per voice claim (12 mo) | $4,437.89 | Duke Health study |
| Share of short-term disability claims due to voice disorders | 2.1% (of 18,466) | Duke Health study |
| Teacher presenteeism cost, Miami-Dade schools | ~$12 million/year | Miami-Dade Public Schools study |
| People with voice disorders who see a doctor | 5% to 20% | Duke Health study |
Outlier note: the 11-to-13-billion-dollar direct-cost figure dates to 2009 and remains the most widely cited estimate available; treat it as a floor pending an updated national costing. Primary source: Duke Health summary.
6. Treatment, Outcomes, and the Dysphonia Market
Outcomes are strong when patients actually reach and complete therapy, which most do quickly. A study of 560 adults found voice therapy averaged about 5.3 sessions, with 89 percent finishing within eight sessions, though success rates swing widely by diagnosis. Surgical and prosthetic pathways report the highest raw success; behavioral therapy for atrophy the lowest, underscoring that the condition, not the method, drives the numbers.
| Metric | Value | Source |
|---|---|---|
| Average voice therapy sessions to completion | ~5.3 (89% within 8) | Voice-therapy outcomes study (560 adults) |
| Unilateral vocal fold paralysis, complete closure after therapy | 69.2% | Voice-therapy paralysis study, PMC |
| Vocal fold atrophy, therapy success (VHI improvement >5) | 36% | Voice-therapy atrophy study, PMC 2023 |
| Tracheoesophageal voice prosthesis, success rate | 94% | Prosthetic rehabilitation study |
| Spasmodic dysphonia treatment market (2026) | $15.08 billion | The Business Research Company, 2026 |
| Muscle tension dysphonia treatment market (2025) | $13.33 billion | Market report, 2025 |
| Voice prosthesis devices market (2025 to 2035) | $0.95B to $1.6B | Market Research Future |
Context: patient compliance with daily home practice of 15 to 20 minutes is consistently the strongest predictor of success across studies. Streamers and remote workers managing vocal load often reach for tooling like streamer voice effects as one part of vocal-hygiene routines, though software is no substitute for clinical care. Primary sources: spasmodic dysphonia market report and the vocal fold atrophy therapy study.
Summary: Voice Disorders by the Numbers
| Metric | Value | Source |
|---|---|---|
| Adults reporting a voice problem in past year (2022) | 29.9 million (12.2%) | Naunheim et al., The Laryngoscope 2024 |
| Dysphonia rise, 2012 to 2022 | 7.62% to 11.71% | Am. J. Speech-Language Pathology, 2024 |
| Lifetime prevalence, national survey | ~1 in 5 | Huston et al., The Laryngoscope 2024 |
| Long-COVID adults with voice complaints vs without | 21.1% vs 11.6% | Naunheim et al., The Laryngoscope 2024 |
| Teachers, pooled point prevalence | 37.7% | Journal of Voice, 2025 |
| Teachers, lifetime prevalence | 63.1% | Journal of Voice, 2025 |
| Call center employees, pandemic-era prevalence | 57.6% | Call-center study, 2024 |
| Professional voice users, prevalence | ~50% | ASHA Practice Portal |
| Treatment-seeking dysphonia point prevalence | 0.98% | Cohen et al., The Laryngoscope 2012 |
| Vocal nodules, general population | 1.31% | Epidemiological study, PMC 2017 |
| Spasmodic dysphonia, U.S. cases | 10,000 to 30,000 | National Spasmodic Dysphonia Association |
| Laryngeal cancer, new U.S. cases (2026) | 12,290 | American Cancer Society, 2026 |
| Older adults, pooled prevalence | 18.79% | Am. J. Speech-Language Pathology, 2023 |
| Women vs men, lifetime prevalence | 46.3% vs 36.9% | Gender-differences study, PMC 2022 |
| U.S. direct healthcare cost | $11 to 13 billion | Cohen et al., via Duke Health |
| Workdays lost per short-term disability claim | 39.2 | Duke Health study |
| People with voice disorders who see a doctor | 5% to 20% | Duke Health study |
| Spasmodic dysphonia treatment market (2026) | $15.08 billion | The Business Research Company, 2026 |
Methodology and Sources
Data was gathered by aggregating prevalence surveys, peer-reviewed epidemiological studies, government health statistics, and named market reports published primarily in 2024 through 2026, prioritizing primary sources and cross-referencing figures where multiple studies overlapped.
- National Institute on Deafness and Other Communication Disorders (NIDCD), Quick Statistics About Voice, Speech, Language (updated 2025) - nidcd.nih.gov
- Naunheim et al., Increasing Prevalence of Voice Disorders in the USA: Updates in the COVID Era, The Laryngoscope (2024) - onlinelibrary.wiley.com
- Prevalence of Dysphonia and Dysphagia Among Adults in the United States in 2012 and 2022, American Journal of Speech-Language Pathology (2024) - pubs.asha.org
- Huston et al., Prevalence of Voice Disorders in the United States: A National Survey, The Laryngoscope (2024)
- Cohen et al., Prevalence and Causes of Dysphonia in a Large Treatment-Seeking Population, The Laryngoscope (2012) - pubmed.ncbi.nlm.nih.gov
- The Worldwide Prevalence of Voice Disorders Among Schoolteachers: A Systematic Review and Meta-Analysis, Journal of Voice (2025) - jvoice.org
- Roy et al., Prevalence of Voice Disorders in Teachers and the General Population, Journal of Speech, Language, and Hearing Research (2004) - pubmed.ncbi.nlm.nih.gov
- Prevalence of Voice Problems in Call Center Operators: A Systematic Review, Journal of Voice (2021) - pubmed.ncbi.nlm.nih.gov
- Prevalence of Voice Disorders in Older Adults: A Systematic Review and Meta-Analysis, American Journal of Speech-Language Pathology (2023) - pubs.asha.org
- Gender-Related Differences in the Prevalence of Voice Disorders and Awareness of Dysphonia, PMC (2022) - pmc.ncbi.nlm.nih.gov
- The Prevalence and Factors Associated with Vocal Nodules in the General Population, PMC (2017) - pmc.ncbi.nlm.nih.gov
- American Cancer Society, Key Statistics for Laryngeal and Hypopharyngeal Cancers (2026) - cancer.org
- Duke Health, Voice Disorder Productivity Losses Comparable to Chronic Diseases - corporate.dukehealth.org
- ASHA Practice Portal, Voice Disorders (Incidence and Prevalence)
- Does Voice Therapy Improve Vocal Outcomes in Vocal Fold Atrophy?, PMC (2023) - pmc.ncbi.nlm.nih.gov
- The Business Research Company, Spasmodic Dysphonia Treatment Global Market Report (2026) - researchandmarkets.com
- National Spasmodic Dysphonia Association; Merck Manual (vocal fold lesions); Journal of Speech, Language, and Hearing Research (2016, young adults)
Data watch: the NIDCD Quick Statistics page and the National Health Interview Survey update on annual cycles, with the next NHIS-based prevalence releases expected through 2026 and 2027. The American Cancer Society publishes fresh cancer estimates every January, so 2027 laryngeal cancer figures are due in early 2027. The Journal of Voice and American Journal of Speech-Language Pathology issue new prevalence meta-analyses regularly, and The Business Research Company refreshes its market reports annually.
Last updated: July 12, 2026.
We review and update this page quarterly as new data is published.